Sue Siegel has served on our board since December 2020. Previously, Ms. Siegel served as GE’s Chief Innovation Officer, CEO of GE Ventures & Licensing, and CEO of Healthymagination. Before GE, she was a VC General Partner at Mohr Davidow Ventures, leading investments in Life Sciences & Health. During the early days of the human genome project, Ms. Siegel led Affymetrix from a pre-revenue start up to a multi-billion publicly-listed company that helped shape the emerging genomics industry. Ms. Siegel earned her B.S. in Biology from the University of Puerto Rico – Mayaguez and her M.S. in Biochemistry and Molecular Biology from Boston University School of Medicine. Ms. Siegel currently serves on the boards of Illumina, Align Technology, the Kaiser Family Foundation, and is Chairman of the Board of Directors of MIT’s The Engine.